Search

Inner Mongolia Western Natural Gas Co., Ltd. (Stock Abbreviation: Western Natural Gas; Stock Code: 601138) is a key regional energy enterprise under the jurisdiction of the Inner Mongolia Autonomous Region, established upon approval by the People’s Government of the Inner Mongolia Autonomous Region and controlled by Inner Mongolia Energy Group. The company was listed on the Main Board of the Shanghai Stock Exchange in December 2022 and is positioned as a regional natural gas transmission & distribution and integrated energy service operator. Its core businesses include construction and operation of long-distance natural gas pipelines, urban gas transmission & distribution, LNG production and sales, natural gas-based distributed energy projects, hydrogen energy projects, and other clean energy initiatives. Focusing on multi-energy synergy among “pipeline gas + LNG + hydrogen,” the company provides customized gas supply solutions for industrial users, industrial parks, and transportation sectors; integrated park-level distributed energy system services; and full-lifecycle management services for hydrogen refueling stations. Leveraging a backbone pipeline network exceeding 2,800 kilometers covering leagues and cities including Ordos, Baotou, Hohhot, and Ulanqab, the company serves as both a connecting channel between the Shaanxi-Beijing Pipeline and the West-to-East Gas Transmission Pipeline and the hub of the western Inner Mongolia natural gas trunk network, with a designed annual gas transmission capacity exceeding 12 billion cubic meters. Technologically, the company operates an autonomous-region-level enterprise technology center and possesses engineering capabilities including intelligent inspection in frigid regions, domestication and integration of SCADA systems, and digital twin modeling of station facilities. It holds 17 utility model patents and has participated in drafting multiple local standards. The company holds the following licenses and qualifications: Gas Business License; Pressure Pipeline Design/Installation License; Hazardous Chemicals Business License; LNG Refueling Station Operation Qualification; and certain Power Business Licenses (Supply Category). All key operational stations have passed certification under ISO 9001, ISO 14001, and ISO 45001. Representative projects include the E’erduosi–Hohhot–Zhangjiakou Gas Transmission Pipeline (a sub-project under the State’s “14th Five-Year Plan” 102 Major Projects), the Hohhot New Airport Natural Gas Supply Project, the Baotou Hydrogen Demonstration Hydrogen Refueling Mother Station, and Inner Mongolia’s first pure-hydrogen transmission pilot pipeline. While centered in Inner Mongolia, the company’s business extends to North China regions including Shanxi, Hebei, and Beijing, deeply supporting clean energy supply assurance for the Beijing-Tianjin-Hebei region and implementation of the northern “coal-to-gas” policy. In 2023, it supplied 4.23 billion cubic meters of gas to key industrial parks within the region, accounting for approximately 61% of total pipeline gas sales in western Inner Mongolia. We sincerely invite government platforms, industrial parks, energy users, and industry-chain partners to engage in pragmatic cooperation across areas including joint pipeline infrastructure development, complementary multi-energy systems, hydrogen energy applications, and digitalized operation & maintenance.

Inner Mongolia Qinghua Group Tengger Coal Coking Co., Ltd. is a core enterprise under Inner Mongolia Qinghua Group Co., Ltd., primarily engaged in coal coking. It serves as a pivotal link—connecting upstream and downstream operations—in the Northwest Region’s circular economy industrial chain of “coal–coke–chemicals–power generation–building materials.” The company’s main business includes coke production (annual capacity: 2.2 million tons), alongside comprehensive recovery and integrated utilization of coking by-products (e.g., coal tar, crude benzene, ammonium sulfate, and coke oven gas). Supporting facilities include dry quenching of coke, chemical products recovery, waste heat power generation (2 × 15 MW), and regional collaborative utilization systems for coke oven gas. Its technological approach adopts China’s mainstream stamp-charging coking process, enabling highly efficient recovery of sensible heat from coke and multi-path consumption of coke oven gas. The company has obtained certifications for ISO 9001 Quality Management System, ISO 14001 Environmental Management System, and ISO 45001 Occupational Health and Safety Management System; holds the “Work Safety Production License,” “National Industrial Product Production License (Coke),” and “Pollutant Discharge Permit”; and has completed ultra-low emission retrofitting, passing municipal-level acceptance. Its emissions consistently meet standards stricter than the special emission limits stipulated in the national standard “Emission Standard of Pollutants for Coking Chemical Industry” (GB 16171-2012), qualifying it as an Autonomous Region-level Clean Production Demonstration Enterprise. Its coke is primarily supplied to steel enterprises in the Northwest Region; part of its coke oven gas is delivered to downstream chemical enterprises—including methanol and ammonia synthesis plants—within the industrial park, fostering regional industrial synergy. Deep processing of coal tar yields primary chemical raw materials such as industrial naphthalene and phenols. The company holds three utility model patents related to energy-saving coking equipment. Its production and business operations have remained continuously stable in recent years, with no overseas business activities conducted. Targeting upstream and downstream links in the industrial chain, pragmatic cooperation opportunities exist in areas including stable coke supply, resource-based utilization of coke oven gas, optimization of waste heat recovery systems, technical collaboration on dry quenching of coke and chemical products recovery, and support for clean production retrofitting.

Inner Mongolia Junye Biopharmaceutical Co., Ltd. is a veterinary biologics R&D and manufacturing enterprise based in Inner Mongolia and serving the national animal husbandry industry. The company specializes in the R&D, production, and sales of animal vaccines and immune enhancers. Its core business covers 12 products approved by the Ministry of Agriculture and Rural Affairs, including inactivated avian influenza (H9 subtype) vaccine, Newcastle disease–infectious bronchitis bivalent inactivated vaccine, and porcine circovirus type 2 (PCV2) inactivated vaccine. These products are primarily applied in disease prevention and control scenarios for large-scale poultry farming. The company has established a Biosafety Level 3 (BSL-3) laboratory and an SPF chicken embryo culture platform compliant with the “Good Manufacturing Practice for Veterinary Drugs (2020 Revision).” It possesses proprietary high-density suspension cell culture technology and heat-resistant protective agent formulation technology, both of which have been applied to the large-scale production of H9N2 subtype avian influenza inactivated vaccine. The company holds three authorized invention patents (focusing on antigen purification and adjuvant compounding) and five utility model patents (covering filling equipment and cold-chain monitoring devices). It holds a valid Veterinary Drug GMP Certificate ((2021) Veterinary Drug GMP Cert. No. 017, valid until November 2026) and a Veterinary Drug Production License (Veterinary Drug Production License No. 05016.GMP), and has passed ISO 9001:2015 Quality Management System Certification. It has been included in the Inner Mongolia Autonomous Region’s “Specialized, Refined, Distinctive, and Innovative” (Zhuan Jing Te Xin) Small and Medium-sized Enterprise Cultivation Database (2024). Its “Junye”-branded series of poultry vaccines has achieved stable market coverage across North China, Northeast China, and Northwest China; some products have been included in the Inner Mongolia Autonomous Region Animal Husbandry and Agriculture Technology Extension General Station’s Recommended Catalogue for 2024. The company provides customized vaccine supply, process technical support, joint experimental verification, and regional disease prevention and control solutions to livestock farming groups, veterinary pharmaceutical distributors, regional animal disease prevention institutions, and scientific research institutes.

Inner Mongolia Huaxin Pharmaceutical Co., Ltd. is a high-tech enterprise specializing in the research and development, production, and sales of chemical active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, positioning itself as a specialized manufacturer in the fields of chiral drugs and green manufacturing processes. The company’s core business encompasses large-scale GMP-compliant production of APIs—including levamisole hydrochloride, metronidazole, and fluconazole—as well as a series of pharmaceutical intermediates; its products are widely used in the production of anti-infective, anthelmintic, and antifungal formulations. Leveraging its provincial-level enterprise R&D center, the company focuses on chiral drug resolution and optimization of green crystallization processes, holding five invention patents—including “A Crystallization and Purification Method for High-Purity Levamisole Hydrochloride”—with core technologies enabling stable mass production characterized by high purity, high yield, and low environmental impact. The company holds a “Pharmaceutical Production License” (No. Nei 20160008), authorizing production of APIs and tablets; its levamisole hydrochloride API has been approved by China’s National Medical Products Administration (NMPA) (Registration No. H15020882), making it one of only a few enterprises in China possessing large-scale GMP-compliant production capability for this product. Additionally, the company has obtained ISO 9001:2015 Quality Management System certification and passed the Level-3 Standardization Assessment for Work Safety. In 2021, the company filed and completed construction of the “Technical Renovation Project for an Intelligent Production Line with an Annual Capacity of 300 Tons of High-End Pharmaceutical Intermediates,” establishing foundations for intelligent and continuous production. Its customers include leading pharmaceutical enterprises across North and East China, and it has already entered the supply chains of listed companies such as North China Pharmaceutical Group and Lunan Pharmaceutical Group. Currently, the company primarily serves domestic pharmaceutical enterprises by providing customized APIs and intermediates, technical collaboration, and production capacity support; it has not yet undertaken overseas registration or export operations.

Inner Mongolia Ordos Power Metallurgy Group Co., Ltd. Chlor-Alkali Chemical Branch is a specialized production unit under Ordos Power Metallurgy Group, focusing exclusively on the chlor-alkali chemical sector. Leveraging the Group’s integrated circular economy industrial chain—“coal → power → ferrosilicon/chlor-alkali → downstream deep processing”—the Branch undertakes large-scale production and sales of caustic soda, polyvinyl chloride (PVC), calcium carbide, hydrochloric acid, liquid chlorine, sodium hypochlorite, and other chlor-alkali-related products. The Company operates a stable 300,000-ton-per-year ion-exchange membrane caustic soda plant and a 400,000-ton-per-year PVC plant, utilizing fully automated DCS control systems and advanced membrane-distance electrolytic cell technology; its energy consumption level exceeds the limits stipulated in the national “Access Conditions for the Chlor-Alkali Industry.” Complementary self-owned cogeneration thermal power facilities and a project for comprehensive utilization of calcium carbide slag to produce cement clinker further highlight its pronounced resource-circular characteristics. All products strictly comply with national standards, including GB/T 5761–2018 (PVC) and GB 209–2018 (caustic soda); certain high-purity flake caustic soda is supplied specifically to photovoltaic polysilicon producers in Northwest China. The Company has obtained certification for the three major management systems—ISO 9001 (Quality), ISO 14001 (Environment), and ISO 45001 (Occupational Health and Safety)—and holds all legally mandated permits, including the “Work Safety Production License,” the “National Industrial Product Production License (Chlor-Alkali Category),” and the “Pollutant Discharge Permit.” As one of the key chlor-alkali production bases in the Inner Mongolia Autonomous Region, its products primarily serve markets in North China and Northwest China. All external information is uniformly disseminated via the parent company’s official website (www.ordos-powermet.com) and the WeChat public account “Ordos Power Metallurgy Group.” The Company actively seeks pragmatic coordination and in-depth collaboration in areas such as procurement of chemical raw materials, collaborative circular economy projects, green manufacturing technology partnerships, and upstream-downstream industrial chain integration.

Inner Mongolia Eji Nuor Salt Co., Ltd. is a state-designated edible salt production enterprise (Certificate No.: XYD20231500001), affiliated with Inner Mongolia Energy Group Co., Ltd. and supervised by the State-owned Assets Supervision and Administration Commission of the Inner Mongolia Autonomous Region. Its predecessor was the Eji Nuor Salt Field, established in 1951. Leveraging the natural resources of the Eji Nuor Salt Lake, the company focuses on the integrated development of the lake salt industry chain. Its core businesses include raw salt mining; refined salt and diversified edible salt products (e.g., low-sodium salt, calcium-enriched salt, zinc-iodized salt, and other nutritionally fortified salts); industrial salt; de-icing agents; and development of salt chemical by-products. The company’s annual raw salt production capacity is approximately 300,000 tons, and its refined salt production capacity exceeds 150,000 tons. The enterprise possesses advantages of natural solar evaporation processing; its products are naturally rich in trace elements such as magnesium and potassium; and it complies with GB 2721–2015 “National Food Safety Standard—Edible Salt” and GB/T 5461–2016 “Edible Salt.” It has obtained ISO 22000 Food Safety Management System Certification (Certificate No.: FSMS-2022-1587) and ISO 9001 Quality Management System Certification (Certificate No.: QMS-2022-3492). “Eji Nuor” is a renowned trademark of Inner Mongolia (certified in 2021) and has been included in the “Preliminary Projects List of Key Protected Geographical Indications of the Inner Mongolia Autonomous Region (2023 Edition).” The company has established an autonomous regional-level Salt Industry Engineering Technology Research Center, holds three utility model patents and two software copyrights, and participated in revising the industry standard “Lake Salt” (QB/T 5842–2023). As the designated edible salt reserve undertaking unit for the Inner Mongolia Autonomous Region, it manages an annual reserve volume of 50,000 tons, with a distribution network covering all 12 leagues and cities across the region. Concurrently, the company advances green mine construction; in 2023, it passed the on-site verification for inclusion in the Ministry of Natural Resources’ Green Mine Selection Program, having cumulatively implemented ecological restoration over an area of 1,200 mu. Currently, the company primarily serves the domestic market, with cooperation areas including edible salt supply, customized development of nutritionally fortified salts, supporting industrial salt provision, regional de-icing agent assurance, and collaborative salt chemical technology development.

Inner Mongolia Daquan New Energy Co., Ltd. is a wholly owned subsidiary of Jiangsu Daquan Group Co., Ltd. established in Northwest China, positioned as an integrated clean energy solution provider targeting large-scale solar and wind power bases in desert, Gobi, and wasteland (“Sha-Ge-Huang”) regions. It provides in-depth support for the construction of Inner Mongolia’s northern multi-gigawatt-level new energy base—a key initiative under the national “14th Five-Year Plan” for renewable energy development. The company’s core businesses encompass manufacturing of solar photovoltaic (PV) equipment and components; investment, construction, and operation of PV and wind power projects; research, development, and manufacturing of wind turbine generators and components; integration of novel energy storage systems; and development of intelligent microgrid technologies—focusing specifically on the solar power generation and wind power generation subsectors. Leveraging the national-level enterprise technology center and postdoctoral research workstation of Daquan Group, the company has accumulated technical expertise in areas including multilevel topology optimization of PV inverters, dynamic response control of grid-forming energy storage converters, and anti-icing blade design for wind turbines operating in high-cold regions. As of the end of 2024, it holds 12 valid invention patents and 37 utility model patents, and has led or participated in formulating three group standards, including the “Technical Code for Freeze-Thaw Prevention Construction of Photovoltaic Power Stations in Plateau and High-Cold Regions.” The company holds a Grade III General Contracting Qualification for Electric Power Engineering Construction and a License for Installation (Maintenance/Testing) of Electric Power Facilities (Grade III for Installation and Grade III for Testing), and has obtained ISO 9001, ISO 14001, and ISO 45001 management system certifications. Its energy storage system integration products have received the “Grid-Forming Energy Storage System Grid-Connection Performance Test Certification” issued by the China Electric Power Research Institute. The company has completed and connected to the grid PV projects with a total installed capacity of 870 MW, including representative projects such as the 200-MW agrivoltaic project in Damuqi, Baotou, and the 300-MW grid-parity project in Wulateqianqi, Bayannur. It has also supplied equipment and provided system integration services for Phase I of the integrated source-grid-load-storage demonstration project in Zhenglan Banner, Xilingol League. All current projects are located within the Inner Mongolia Autonomous Region and are closely integrated into the Mongolian West Power Grid’s new energy consumption system. The company offers diverse collaboration models—including independent investment, EPC general contracting, supply of core equipment, system integration, and technical collaboration—to local governments, energy investors, grid enterprises, and industrial chain partners.

Inner Mongolia Boyuan United Chemical Co., Ltd. is a modern coal chemical industry specialized operating entity controlled by Inner Mongolia Boyuan Holding Group Co., Ltd. It falls under the chemical raw materials and chemical products manufacturing industry, focusing on the mid- and downstream segments of the coal chemical industry value chain. Its core business covers the production and sales of fundamental chemical products such as ammonia, urea, and methanol, and it concurrently undertakes public utility support and environmental protection facility operation tasks for coal-to-natural gas and coal-to-olefins projects. Leveraging the platforms of Boyuan Group’s national-level enterprise technology center and the Inner Mongolia Autonomous Region Coal Chemical Engineering Technology Research Center, the company has accumulated robust technical expertise in energy conservation, carbon emission reduction, and process optimization. It has practically implemented the “Integrated Technology for Purification of Associated Gas from High-Concentration CO₂ Enhanced Oil Recovery,” and is responsible for the energy-saving retrofitting of ammonia synthesis units and the stable operation of CO₂ capture pre-treatment modules. The company has obtained certifications for ISO 9001 Quality Management System, ISO 14001 Environmental Management System, and ISO 45001 Occupational Health and Safety Management System, all valid through 2026. As a key implementing unit of Boyuan Group’s Sulige Economic Development Zone coal chemical industry base, its products and services primarily serve the fertilizer and chemical raw material markets in North China and Northwest China, and it deeply participates in regional green upgrading initiatives within the coal chemical industry. In terms of collaboration, the company offers upstream and downstream industrial chain partners stable supply of fundamental chemical raw materials, coordinated operational support for supporting public utilities, technical validation and engineering implementation cooperation opportunities for decarbonization units, and entrusted operation services for environmental protection facilities based on its mature management system. All information originates from authoritative sources, including Boyuan Group’s publicly released reports, official platforms of the Inner Mongolia Autonomous Region Department of Industry and Information Technology and Department of Ecology and Environment, and the National Enterprise Credit Information Publicity System.

Inner Mongolia Anzhou Pharmaceutical Co., Ltd. is a high-tech enterprise specializing in the research and development, production, and sales of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, with a strategic focus on niche segments including quinolone- and catecholamine-based APIs. The company’s core business encompasses the large-scale production of approved APIs such as dopamine hydrochloride and pazufloxacin mesylate, as well as the customized development and supply of related pharmaceutical intermediates. Its products are widely used in the manufacturing of injectable formulations and have established stable supply capabilities to numerous pharmaceutical enterprises across North China and East China; they are also exported to emerging markets including India and Brazil. The enterprise possesses a complete technical chain—from process development and pilot-scale amplification to industrial implementation—with core competencies centered on chiral synthesis, continuous-flow reaction, and control technologies for highly active impurities. In 2023, the company completed intelligent production line transformation, fully deploying a Distributed Control System (DCS) and an Electronic Batch Record (EBR) system, compliant with data integrity requirements under the latest Good Manufacturing Practice (GMP) guidelines. The company holds a “Pharmaceutical Production License” (Category Code: Hb). Dopamine hydrochloride has passed review by China’s National Medical Products Administration (NMPA) and obtained European Directorate for the Quality of Medicines & HealthCare (EDQM) Certification of a Suitability of the Monograph to the Substance (CEP) (CEP 2022-045-S); pazufloxacin mesylate received marketing authorization from China’s NMPA in 2024 (Registration No.: H20240012). The company owns five valid invention patents and three utility model patents, all covering key technologies related to green synthesis and quality control. It has established an autonomous regional-level enterprise technology center and participated in drafting the group standard “Guideline for Quality Risk Management of Continuous Manufacturing Processes for Chemical APIs” (T/CNPPA 3012—2024). The company is certified to ISO 9001:2015 and ISO 14001:2015 standards and has been recognized as a Level-3 Enterprise for Standardization of Work Safety. It provides compliant API supply, collaborative process development, technology transfer, and customized intermediate solutions to pharmaceutical enterprises, CDMO organizations, and international clients.

Nanjing Suxia Design Group Co., Ltd. (Stock Abbreviation: Suxia Design; Stock Code: 873589) is a national high-tech enterprise whose core businesses include engineering consulting, engineering design, engineering procurement and construction (EPC) contracting, and whole-process engineering consulting services. The company has long focused on providing systematic solutions for sectors such as energy & chemical industry, municipal environmental protection, new materials, and dual-carbon technologies. Its main business covers pre-project consulting (including feasibility studies, energy conservation assessments, and carbon peak pathway studies), engineering design (Class A in the chemical, petrochemical, and pharmaceutical industries), EPC contracting, and specialized green and low-carbon services (e.g., industrial energy efficiency diagnostics, green factory evaluations, circular transformation of industrial parks, and CCUS engineering applications). Leveraging its independently developed “Suxia Carbon Manager” digital platform and multiple energy-saving and carbon-reduction modeling tools, the company possesses robust capabilities in integrating low-carbon technologies and translating them into engineering applications. The company holds numerous national-level qualifications, including Class A credit rating for engineering consulting firms (in petroleum & chemical, chemical, pharmaceutical, ecological construction, and environmental engineering fields); Class A engineering design qualification for the chemical, petrochemical, and pharmaceutical industries; Class B engineering design qualification for the architectural industry (building engineering); Class B engineering supervision qualification for chemical and petroleum projects; and special equipment design permits for pressure pipelines (categories GA/GC). Additionally, the company has obtained certifications for the ISO 9001, ISO 14001, and ISO 45001 management systems. As of 2023, it holds six authorized invention patents, 32 utility model patents, and 28 software copyrights. Representative projects include the energy system planning for the Lianyungang Xuwei New Area Petrochemical Base, the feasibility study and basic design for the one-million-ton-per-year ethylene project in Ningbo, Zhejiang Province, and the carbon peak pathway study for a chemical industrial park in Jiangsu Province. Its clients include major energy and chemical groups such as Sinopec, CNOOC, Hengli Petrochemical, Shenghong Refining & Chemical, and Wanhua Chemical. Geographically, its services are primarily concentrated in East China, extending to North China, South China, and Central/Western China; it currently does not engage in overseas engineering consulting or international business operations. We welcome pragmatic collaboration in areas such as engineering consulting, green and low-carbon technical services, EPC project partnerships, and joint application of digital platforms.